PG&E Corporation (NYSE:PCG) , a diversified utility holding company, engages in the business of electricity and natural gas distribution; electricity generation, procurement, and transmission; and natural gas procurement, transportation and storage.
Stable financial position, steady growth in customer counts, a well-set of utility assets and disciplined investments in infrastructure projects will likely boost PG&E Corp.’s future performance In addition, the company’s practice of paying dividend is commendable.
However, warmer-than-normal winter remain potential setbacks.
Estimate Trend & Surprise History
Investors should note that the first-quarter Zacks Consensus Estimate for earnings of $1.03 per share remained unchanged in the last 7 days.
Coming to the earnings surprise history, PG&E Corporation has surpassed the Zacks Consensus Estimate in three out of last four quarters, resulting in a positive average surprise of 11.76%.
Zacks Rank: Currently, PG&E Corporation has a Zacks Rank #3 (Hold) but that could change following its first quarter 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have mentioned below some of the vital information from this just-revealed announcement:
Earnings: PG&E Corporation’s earnings were below our earnings estimates. The company's adjusted earnings per share came in at 91 cents per share, which missed the Zacks Consensus Estimate of $1.03 per share by 11.7%.
Revenue: PG&E Corporation’s total revenue of $4,056 million also missed the Zacks Consensus Estimate of $4,233 million by 4.2%.
Key Stats: Lower year-over-year revenues from electric and natural gas segments led to lower earnings in first quarter.
Stock Price: In the pre-market trading session, PG&E Corporation’s first-quarter results made no significant impact on its share price. Yet, it would be interesting to see how the market reacts to the earnings release during the trading session today.
Check back later for our full write up on this PCG earnings report later!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Pacific Gas & Electric Co. (PCG): Free Stock Analysis Report
Original post
Zacks Investment Research